Wiesbaden, Germany

Eva Danuta Allen

This inventor holds 1 USPTO granted patent. Top assignee: Agfa-Gevaert. Active years: 2001.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eva Danuta Allen: Innovator in Ceramic Layer Technology

Introduction

Eva Danuta Allen is a prominent inventor based in Wiesbaden, Germany. She has made significant contributions to the field of materials science, particularly in the development of innovative recording materials. Her work focuses on enhancing the performance and durability of printing plates through advanced ceramic layer technology.

Latest Patents

Eva holds a patent for a unique recording material that comprises a substrate and a ceramic layer applied to the surface of the substrate. This ceramic layer consists of aluminum oxide and a silicate compound, which acts as a binder to ensure strong adhesion to the substrate. This innovation is crucial for improving the quality and longevity of printing processes.

Career Highlights

Eva Danuta Allen is currently employed at Agfa-Gevaert, a leading company in imaging and printing technology. Her role involves research and development, where she applies her expertise to create cutting-edge solutions for the industry. With her innovative mindset, she has contributed to the advancement of printing technologies.

Collaborations

Eva has collaborated with her coworker, Michael Brenk, to further enhance the research and development efforts at Agfa-Gevaert. Their teamwork has led to significant advancements in the field of ceramic materials for printing applications.

Conclusion

Eva Danuta Allen's contributions to the field of materials science and her innovative patent demonstrate her commitment to advancing technology in the printing industry. Her work continues to influence the development of high-performance recording materials.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…